TP53 and cancer: This corresponds to a total of 2303 associations of a drug to specific gene mutational status by cancer type (total number of tests ignoring TP53 n = 486,417 versus n = 402,945 controlling for TP53 status, Additional file 1: Fig. S10c,d).